Ignite Creation Date:
2024-05-05 @ 10:01 AM
Last Modification Date:
2024-10-26 @ 9:05 AM
Study NCT ID:
NCT00006068
Status:
UNKNOWN
Last Update Posted:
2005-06-24
First Post:
2000-07-18
Brief Title:
Does Islet Transplantation Eliminate Hypoglycemia
Sponsor:
National Center for Research Resources NCRR
Organization:
National Center for Research Resources NCRR
Study Overview
Official Title:
None
Status:
UNKNOWN
Status Verified Date:
2001-11
Last Known Status:
NOT_YET_RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Low blood sugar hypoglycemia is a recurrent problem for many people with diabetes Successful transplantation of clusters islets of normal cells that include those which produce the sugar-lowering hormone insulin from the pancreas of a person who did not have diabetes into a person with diabetes should eliminate high blood sugar levels We wish to determine if it will also eliminate low blood sugar To do so we will give insulin to lower the blood sugar measure the levels of the hormones that normally raise blood sugar levels eg glucagon and epinephrine and then stop the insulin and see if blood sugar levels return to normal Because we anticipate that the transplanted islets will produce insulin but not glucagon this study may also tell us if regulated insulin production alone can prevent hypoglycemia in humans
Detailed Description:
None
Study Oversight
Has Oversight DMC:
Is a FDA Regulated Drug?:
Is a FDA Regulated Device?:
Is an Unapproved Device?:
Is a PPSD?:
Is a US Export?:
Is an FDA AA801 Violation?:
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| M01RR000036 | NIH | None | httpsreporternihgovquickSearchM01RR000036 |